{"article_title": "EarlySense gets FDA device approval for patient monitor update with benchmarking tool", "article_keywords": ["fda", "received", "updated", "patient", "monitor", "tool", "update", "system", "pressure", "rate", "earlysense", "version", "device", "approval", "gets", "patients", "benchmarking"], "article_url": "http://medcitynews.com/2014/01/earlysense-gets-fda-clearance-updated-bedside-patient-monitor-adding-patient-safety-tools/", "article_text": "Medical device maker EarlySense has received a green light for an updated version of its FDA-approved patient monitoring device. The tool uses a pad-sized sensor that fits under the mattress to transmit data on respiration and heart rate as well as movement to a bedside monitor and a monitor at a nurse station. The updated version \u2014 EarlySense 2.0 \u2014 adds a benchmarking tool to track and analyze hospital staff\u2019s performance to prevent falls and pressure ulcers.\n\nThe benchmark analysis reports are provided by EarlySense as part of the clinical implementation process.\n\nThe system was initially designed to monitor non-ICU, lower risk patients on medical surgical floors who are usually monitored by nursing staff approximately once every four hours, according to the company\u2019s website. The Israeli company\u2019s U.S. headquarters are in Waltham, Mass. In 2012, the company received regulatory approval to add an oxymetry tool for patients coming out of surgery who require a higher level of supervision.\n\nAdvertisement\n\nThe patient monitoring system also responds to the alarm fatigue hazard that can accompany some devices by alerting nurses about changes in a patient\u2019s heart rate only when those changes have exceeded a certain threshold.\n\nTim O\u2019Malley, EarlySense president, has said the company has seen a surge in interest in its devices since the roll out of the Affordable Care Act as a way to reduce risks such as falls and pressure ulcers that can ramp up hospitalization costs.\n\nFollow MedCity News on Facebook and Twitter for more updates.", "article_metadata": {"description": "Medical device maker EarlySense has received a green light for an updated version of its FDA-approved patient monitoring device. The tool uses a pad-sized sensor that fits under the mattress to transmit data on respiration and heart rate as well as movement to a bedside monitor and a monitor at a nurse station. The updated version \u2014 EarlySense 2.0 \u2014 adds a benchmarking tool to track and analyze hospital staff\u2019s performance to prevent falls and pressure ulcers. The benchmark analysis reports are provided by EarlySense as part of the clinical implementation process. The system was initially designed to monitor non-ICU, lower risk patients on medical surgical floors who are usually monitored by nursing staff approximately once every four hours, according to the company\u2019s website. The Israeli company\u2019s U.S. headquarters are in Waltham, Mass. In 2012, the company received regulatory approval to add an oxymetry tool for patients coming out of surgery who require a higher level of supervision. The patient monitoring system also responds to the alarm fatigue hazard that can accompany some devices by alerting nurses about changes in a patient\u2019s heart rate only when those changes have exceeded a certain threshold. Tim O\u2019Malley, EarlySense president, has said the company has seen a surge in interest in its devices since the roll out of the Affordable Care Act as a way to reduce risks such as falls and pressure ulcers that can ramp up hospitalization costs. Follow MedCity News on Facebook and Twitter for more updates.", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Medical device maker EarlySense has received a green light for an updated version of its FDA-approved patient monitoring device. The tool uses a pad-sized sensor that fits under the mattress to transmit data on respiration and heart rate as well as movement to a bedside monitor and a monitor at a nurse station. The updated version \u2014 EarlySense 2.0 \u2014 adds a benchmarking tool to track and analyze hospital staff\u2019s performance to prevent falls and pressure ulcers. The benchmark analysis reports are provided by EarlySense as part of the clinical implementation process. The system was initially designed to monitor non-ICU, lower risk patients on medical surgical floors who are usually monitored by nursing staff approximately once every four hours, according to the company\u2019s website. The Israeli company\u2019s U.S. headquarters are in Waltham, Mass. In 2012, the company received regulatory approval to add an oxymetry tool for patients coming out of surgery who require a higher level of supervision. The patient monitoring system also responds to the alarm fatigue hazard that can accompany some devices by alerting nurses about changes in a patient\u2019s heart rate only when those changes have exceeded a certain threshold. Tim O\u2019Malley, EarlySense president, has said the company has seen a surge in interest in its devices since the roll out of the Affordable Care Act as a way to reduce risks such as falls and pressure ulcers that can ramp up hospitalization costs. Follow MedCity News on Facebook and Twitter for more updates.", "title": "EarlySense gets FDA device approval for patient monitor update with benchmarking tool", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/everon_pic.gif", "updated_time": "2014-01-09T09:50:56-04:00", "url": "http://medcitynews.com/2014/01/earlysense-gets-fda-clearance-updated-bedside-patient-monitor-adding-patient-safety-tools/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/everon_pic.gif", "description": "Medical device maker EarlySense has received a green light for an updated version of its FDA-approved patient monitoring device. The tool uses a pad-sized sensor that fits under the mattress to transmit data on respiration and heart rate as well as movement to a bedside monitor and a monitor at a nurse station. The updated version \u2014 EarlySense 2.0 \u2014 adds a benchmarking tool to track and analyze hospital staff\u2019s performance to prevent falls and pressure ulcers. The benchmark analysis reports are provided by EarlySense as part of the clinical implementation process. The system was initially designed to monitor non-ICU, lower risk patients on medical surgical floors who are usually monitored by nursing staff approximately once every four hours, according to the company\u2019s website. The Israeli company\u2019s U.S. headquarters are in Waltham, Mass. In 2012, the company received regulatory approval to add an oxymetry tool for patients coming out of surgery who require a higher level of supervision. The patient monitoring system also responds to the alarm fatigue hazard that can accompany some devices by alerting nurses about changes in a patient\u2019s heart rate only when those changes have exceeded a certain threshold. Tim O\u2019Malley, EarlySense president, has said the company has seen a surge in interest in its devices since the roll out of the Affordable Care Act as a way to reduce risks such as falls and pressure ulcers that can ramp up hospitalization costs. Follow MedCity News on Facebook and Twitter for more updates.", "card": "summary", "title": "EarlySense gets FDA device approval for patient monitor update with benchmarking tool - MedCity News"}, "fb": {"app_id": 148725768475669}, "article": {"section": "Daily", "tag": "Massachusetts", "published_time": "2014-01-08T14:38:25-04:00", "modified_time": "2014-01-09T09:50:56-04:00"}, "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,Boston, EarlySense, FDA Device Approvals, Massachusetts, , MedCity News", "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "_id": "\"57477af36914bd0286fd15e8\"", "article_summary": "Medical device maker EarlySense has received a green light for an updated version of its FDA-approved patient monitoring device.\nThe updated version \u2014 EarlySense 2.0 \u2014 adds a benchmarking tool to track and analyze hospital staff\u2019s performance to prevent falls and pressure ulcers.\nIn 2012, the company received regulatory approval to add an oxymetry tool for patients coming out of surgery who require a higher level of supervision.\nThe tool uses a pad-sized sensor that fits under the mattress to transmit data on respiration and heart rate as well as movement to a bedside monitor and a monitor at a nurse station.\nThe benchmark analysis reports are provided by EarlySense as part of the clinical implementation process."}